
Laura Lynne Stockton
Examiner (ID: 6934)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8990607
[patent_doc_number] => 20130217888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE'
[patent_app_type] => utility
[patent_app_number] => 13/635097
[patent_app_country] => US
[patent_app_date] => 2011-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8287
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635097
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635097 | PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE | Aug 28, 2011 | Abandoned |
Array
(
[id] => 9552487
[patent_doc_number] => 08759537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => '3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 13/211470
[patent_app_country] => US
[patent_app_date] => 2011-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25794
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211470
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211470 | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents | Aug 16, 2011 | Issued |
Array
(
[id] => 7784773
[patent_doc_number] => 20120046329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/207325
[patent_app_country] => US
[patent_app_date] => 2011-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 48257
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046329.pdf
[firstpage_image] =>[orig_patent_app_number] => 13207325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/207325 | MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOF | Aug 9, 2011 | Abandoned |
Array
(
[id] => 8541173
[patent_doc_number] => RE043833
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2012-11-27
[patent_title] => 'Thiazolidin-4-one derivatives'
[patent_app_type] => reissue
[patent_app_number] => 13/205768
[patent_app_country] => US
[patent_app_date] => 2011-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19222
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/205768 | Thiazolidin-4-one derivatives | Aug 8, 2011 | Issued |
Array
(
[id] => 8854205
[patent_doc_number] => 20130143880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'POSITIVE ALLOSTERIC MODULATORS OF MGLUR2'
[patent_app_type] => utility
[patent_app_number] => 13/814870
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26205
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/814870 | Positive allosteric modulators of MGLUR2 | Aug 4, 2011 | Issued |
Array
(
[id] => 9016413
[patent_doc_number] => 20130231377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'PACTAMYCIN ANALOGS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/813144
[patent_app_country] => US
[patent_app_date] => 2011-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23619
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813144
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813144 | PACTAMYCIN ANALOGS AND METHODS OF USE | Aug 1, 2011 | Abandoned |
Array
(
[id] => 8854390
[patent_doc_number] => 20130144065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS'
[patent_app_type] => utility
[patent_app_number] => 13/810819
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28935
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810819
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810819 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | Jul 28, 2011 | Abandoned |
Array
(
[id] => 8896931
[patent_doc_number] => 08476453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Process for the preparation of dimiracetam'
[patent_app_type] => utility
[patent_app_number] => 13/811727
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2531
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811727 | Process for the preparation of dimiracetam | Jul 24, 2011 | Issued |
Array
(
[id] => 7757086
[patent_doc_number] => 20120029029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'SUBSTITUTED THIAZOL-2-YLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS 11-BETA HSD1 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/189640
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14070
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029029.pdf
[firstpage_image] =>[orig_patent_app_number] => 13189640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/189640 | Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators | Jul 24, 2011 | Issued |
Array
(
[id] => 9055258
[patent_doc_number] => 20130252972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES'
[patent_app_type] => utility
[patent_app_number] => 13/810976
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21208
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810976 | ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES | Jul 18, 2011 | Abandoned |
Array
(
[id] => 9175249
[patent_doc_number] => 20130317234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Process for Preparation of Intermediates of Bendamustine'
[patent_app_type] => utility
[patent_app_number] => 13/877932
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1211
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877932 | Process for Preparation of Intermediates of Bendamustine | Jul 13, 2011 | Abandoned |
Array
(
[id] => 8977379
[patent_doc_number] => 20130210809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/808899
[patent_app_country] => US
[patent_app_date] => 2011-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29270
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808899 | NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | Jul 11, 2011 | Abandoned |
Array
(
[id] => 8780800
[patent_doc_number] => 20130102775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'PHOTOCHROMIC MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/807461
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15128
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807461
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807461 | Photochromic material | Jul 7, 2011 | Issued |
Array
(
[id] => 9153857
[patent_doc_number] => 08586763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Process for producing N-halogenated hydantoins'
[patent_app_type] => utility
[patent_app_number] => 13/176877
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14541
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176877
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/176877 | Process for producing N-halogenated hydantoins | Jul 5, 2011 | Issued |
Array
(
[id] => 9441126
[patent_doc_number] => 08710237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Small molecule inhibitors of kynurenine-3-monooxygenase'
[patent_app_type] => utility
[patent_app_number] => 13/171930
[patent_app_country] => US
[patent_app_date] => 2011-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18574
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13171930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/171930 | Small molecule inhibitors of kynurenine-3-monooxygenase | Jun 28, 2011 | Issued |
Array
(
[id] => 8989271
[patent_doc_number] => 20130216552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'CRTH2 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/809553
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28279
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809553
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809553 | CRTH2 MODULATORS | Jun 23, 2011 | Abandoned |
Array
(
[id] => 9552484
[patent_doc_number] => 08759536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients'
[patent_app_type] => utility
[patent_app_number] => 13/805326
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5640
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805326
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805326 | Rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients | Jun 16, 2011 | Issued |
Array
(
[id] => 9162150
[patent_doc_number] => 20130310427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'INHIBITORS OF HCV NS5A PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/703004
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19424
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703004
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/703004 | INHIBITORS OF HCV NS5A PROTEIN | Jun 8, 2011 | Abandoned |
Array
(
[id] => 8797320
[patent_doc_number] => 08436189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Heterocyclic alkanol derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/117689
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19103
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13117689
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117689 | Heterocyclic alkanol derivatives | May 26, 2011 | Issued |
Array
(
[id] => 8808039
[patent_doc_number] => 08445691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Heterocyclic thiosubstituted alkanol derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/117723
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22803
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13117723
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117723 | Heterocyclic thiosubstituted alkanol derivatives | May 26, 2011 | Issued |